BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
51 hedge funds and large institutions have $22.6M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
76% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 21
Holders
51
Holding in Top 10
–
Calls
$324K
Puts
$40K
Top Buyers
| 1 | +$197K | |
| 2 | +$181K | |
| 3 | +$137K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$82.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$82.3K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$452K | |
| 3 | -$286K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$210K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$177K |